Latest filing published 02 Jun 2016 for Gen Digital Inc., €251k.
Insider track record
No signal scores available.
Closed purchases
Based on 39 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.6%Entry US$20.01 · Close at T+365 US$23.74
- +12.5%Entry US$22.40 · Close at T+365 US$25.19
- +22.7%Entry US$13.04 · Close at T+365 US$16.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael A/ca Brown: trading record in brief
This profile gathers the share dealings of Michael A/ca Brown across 3 companies, led by Gen Digital Inc., Quantum Corp /DE/ and Nektar Therapeutics. We count 83 filings; the first trade dates from 25 April 2006 and the latest from 1 June 2016.
In open-market terms, that means 41 purchases worth €1.1M on one side and 13 sales worth €2.8M on the other. On balance, insiders were net sellers of €1.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 23 share grants and 6 option exercises.
A typical purchase (the median) is worth €9,239. Ninety days after publication, 39 purchases show a median change of +8.2%, with the price up in 87% of them. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 2 June 2016, reports a share grant of €251k in Gen Digital Inc. The last purchase on record was published on 21 August 2015, which is 4,097 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael A/ca Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,208 shares@ US$17.31100.0% of flowCommon StockSEC:0001209191-16-125232:0
- 20,623 shares@ US$19.93Common StockSEC:0001209191-15-069551:0
- 8,300 shares@ US$21.36Common StockSEC:0001209191-15-067432:0Canonical exit: 19 Nov 2015 (T+90)
- 1,100 shares@ US$21.36Common StockSEC:0001209191-15-067432:1Canonical exit: 19 Nov 2015 (T+90)
- 1,700 shares@ US$21.37Common StockSEC:0001209191-15-067432:2Canonical exit: 19 Nov 2015 (T+90)
- 4,700 shares@ US$21.37Common StockSEC:0001209191-15-067432:3Canonical exit: 19 Nov 2015 (T+90)
- 7,400 shares@ US$21.38Common StockSEC:0001209191-15-067432:4Canonical exit: 19 Nov 2015 (T+90)
- 143,758 shares0Common StockSEC:0001209191-15-052935:0
- 600 shares@ US$25.24Common StockSEC:0001209191-14-076376:1
- 1,800 shares@ US$25.25Common StockSEC:0001209191-14-076376:2
- 900 shares@ US$25.26Common StockSEC:0001209191-14-076376:3
- 700 shares@ US$25.27Common StockSEC:0001209191-14-076376:4
- 233 shares@ US$25.28Common StockSEC:0001209191-14-076376:5
- 100 shares@ US$25.29Common StockSEC:0001209191-14-076376:6
- 4,900 shares@ US$25.30Common StockSEC:0001209191-14-076376:7
- 1,567 shares@ US$25.31Common StockSEC:0001209191-14-076376:8
- 1,000 shares@ US$25.32Common StockSEC:0001209191-14-076376:9
- 200 shares@ US$25.33Common StockSEC:0001209191-14-076376:10
- 147,736 shares0Common StockSEC:0001209191-14-059908:0
- 900 shares@ US$21.22Common StockSEC:0001209191-14-034047:0Canonical exit: 11 Aug 2014 (T+90)
- 200 shares@ US$21.23Common StockSEC:0001209191-14-034047:1Canonical exit: 11 Aug 2014 (T+90)
- 300 shares@ US$21.02Common StockSEC:0001209191-14-034043:0Canonical exit: 11 Aug 2014 (T+90)
- 300 shares@ US$21.03Common StockSEC:0001209191-14-034043:1Canonical exit: 11 Aug 2014 (T+90)
- 200 shares@ US$21.06Common StockSEC:0001209191-14-034043:2Canonical exit: 11 Aug 2014 (T+90)
- 700 shares@ US$21.07Common StockSEC:0001209191-14-034043:4Canonical exit: 11 Aug 2014 (T+90)
25 of 77 declarations
